Intelligence

Home / Intelligence

Type
  • All
  • Blog
  • Briefs
  • Case Studies
  • Industry Publications
  • Podcasts
  • Scientific Publications
  • Webinars
  • White Papers
Featured Topic
  • All
  • AIML
  • Analytics
  • APAC
  • Benchmarking
  • Biosimilars
  • CAR-T
  • Cell and Gene Therapy
  • Commercial Data
  • Commercial Operations
  • Competitive Intelligence
  • Contract Analytics
  • Corporate Strategy
  • COVID-19
  • Diabetes
  • Digital Therapeutics
  • Diversity
  • Dynamic Market Intelligence
  • Emerging Life Sciences
  • Europe
  • Evidence Strategy (HEOR)
  • Field Force
  • Forecasting
  • Generative AI
  • Incentive Compensation
  • Inflation Reduction Act
  • Insights
  • International
  • LatAm
  • Launch and Brand Excellence
  • Learning and Development
  • Leslie Orne
  • Marketing
  • MedTech
  • New Product Planning
  • NRDL
  • Obesity
  • Omnichannel
  • Oncology
  • Patient Centricity
  • Patient Finding
  • Patient Services
  • Performance Tracking
  • Pricing and Access
  • Primary Market Research
  • Product Demos
  • Rare Disease
  • Real-World Evidence
  • Scientific Publications
  • Talent Acquisition and Retention
  • United States
Search
Woman overlooking city skyline

White Papers

What Lies Ahead for New Product Launches?

Trinity Life Sciences has been tracking and analyzing the challenges of commercialization and new product launches in the Biopharma industry for years. In this white paper, we explore historical launch performance trends to help predict where launches are headed and what the industry needs to be thinking about to improve commercialization success.

Read Now

Case Studies

Strategic Recommendations About Potential Actions to Shape Bone Health Policy

Trinity completed a detailed analogue assessment to understand how various stakeholders are involved in shaping health policies across markets. Geographic Scope: Client Situation The client wanted to identify best practices as well as the external stakeholders they should consider working with to efficiently shape global bone health policy. Trinity’s Solution Trinity conducted a systematic analogue disease area filtration to understand the disease areas where health policy development is most comparable to the bone health space. Trinity then conducted exhaustive secondary research within each analogue disease area to understand the…

Read Now

Blog

Access and Reimbursement: Access to Digital Therapeutics in a Post-COVID-19 World

Published July 14, 2020

Executive Summary Digital therapeutics (DTx) represent a novel approach to delivering improved clinical outcomes, but the unstructured nature of today’s DTx access process has presented a major hurdle to broader uptake Payers are still at very different stages in their acceptance of DTx, and in contrast with traditional pharmaceuticals, buy-in from senior leadership will be an essential part of the top-down decision-making process for DTx prioritization Pharmacy benefit managers (PBMs) have taken a leadership role in facilitating a pathway for digital therapeutics adoption, and they are likely to…

Read Now

Briefs

Commercial VP/SVP Pipeline Development for Women in Life Sciences

A life science company engaged TGaS Advisors to: Investigate drivers for gender diversity in VP/SVP commercial roles Benchmark high-performing companies (in/ex industry) with above-average numbers of women in executive roles Benchmark the key competencies and skills of women in executive commercial roles Complete the form below to view the brief…

Read Now

Blog

2019 NRDL: Insights for Future Pricing Negotiations in China

Published June 2, 2020

Executive Summary China’s 2019 National Reimbursement Drug List (NRDL) update offers manufacturers key learnings and insights for future NRDL negotiations, particularly with respect to the negotiation tactics used in different disease areas; although in most disease areas the comparative negotiation rule was employed during the 2019 NRDL, the use of a new competitive negotiation rule employed in the hepatitis C disease area characterized the 2019 NRDL negotiations; under this rule, no base price was set and manufacturers were invited to…

Read Now

Briefs

COVID-19 Briefing Series: Launch in the Age of COVID-19

While COVID-19 is grinding world economies to a potentially disastrous halt, the pharmaceutical and biotech industry continues to move forward at a slower pace. How can companies ensure an agile launch despite the uncertainty and ensure launch success during and in a post-COVID-19 world? Publication Access Form…

Read Now

Briefs

COVID-19 Briefing Series: Telehealth as the New Normal

Highlights from Trinity’s Recent Research Focused on Telehealth Since earlier this year when the COVID-19 virus outbreak began and quickly made its way around the globe, the way in which we operate has changed. Virtual communication for personal as well as business interactions is on the rise. Publication Access Form…

Read Now

Briefs

COVID-19 Briefing Series: European HCP Perspectives

Highlights from Trinity’s Recent Research Focused on European HCP The COVID-19 pandemic continues to have an unprecedented impact on our lives and is disrupting businesses as it spreads worldwide. As the EU5 countries comprise some of the most important pharmaceutical markets, and with Italy, Spain and France includes countries which have been impacted significantly from COVID-19, Trinity aimed to understand the impact on HCP engagement with Market Research. Publication access form…

Read Now

Briefs

COVID-19 Briefing Series: Forecasting Peer Connect

Perspectives from 50+ Industry Forecasting Leaders, Highlights from Trinity’s Recent Research Focused on BioPharma Forecasting In a time of peak uncertainty, forecasters are being called on to answer some of the industry’s toughest questions surrounding the impact of COVID-19. Trinity is bringing together the latest data on challenges forecasters have been experiencing over the past few weeks. This research activity is a joint project of Trinity’s Forecasting Center of Excellence and its benchmarking division, TGaS Advisors. Publication Access Form…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.